Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.375 GBX | -2.17% | -.--% | -3.57% |
Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Performance
1 day | -2.17% | ||
6 months | -28.95% | ||
Current year | -3.57% | ||
1 year | -56.45% | ||
3 years | -97.35% | ||
5 years | -98.76% | ||
10 years | -98.91% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-2.17% | -.--% | -3.57% | -56.45% | 2.43M | ||
+0.58% | +5.88% | +29.77% | -0.92% | 49.18B | ||
+1.10% | +2.55% | +1.00% | +22.05% | 42.11B | ||
+4.89% | +2.31% | +50.47% | -7.38% | 40.37B | ||
+0.05% | -1.80% | -5.26% | +14.59% | 28.85B | ||
+1.97% | +3.22% | +13.68% | +56.33% | 26.09B | ||
-0.33% | -3.21% | -22.99% | -28.52% | 18.71B | ||
-0.77% | +8.37% | +8.22% | +2.98% | 13.26B | ||
+1.85% | +4.71% | +32.41% | +92.47% | 12.32B | ||
-0.11% | -1.16% | -1.62% | +20.90% | 11.99B | ||
+1.08% | +4.44% | +24.01% | +27.19% | 11.97B | ||
+0.84% | +6.59% | +2.23% | -2.12% | 10.07B | ||
+3.81% | +7.86% | +36.15% | -6.05% | 7.05B | ||
+1.26% | -1.83% | +15.77% | +93.67% | 6.6B | ||
-3.85% | -7.78% | +3.51% | -36.23% | 6.59B | ||
+5.38% | +2.82% | +37.34% | +48.42% | 6.17B | ||
Average | +0.93% | -0.03% | +13.82% | +15.06% | ||
Weighted average by Cap. | +1.28% | +0.76% | +16.24% | +14.80% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -3.57% | ||
2023 | -60.00% | ||
2022 | -89.33% | ||
2021 | -0.61% | ||
2020 | -44.44% | ||
2019 | +203.06% | ||
2018 | -73.87% | ||
2017 | -28.57% | ||
2016 | -12.50% | ||
2015 | -14.29% | ||
2014 | +16.47% | ||
2013 | +50.25% | ||
2012 | -54.80% | ||
2011 | -31.40% | ||
2010 | +6.61% | ||
2009 | +120.00% | ||
2008 | -86.59% | ||
2007 | -48.75% | ||
2006 | +54.44% | ||
2005 | -0.38% |
- Stock Market
- Equities
- RENE Stock
- Quotes ReNeuron Group plc